Vanguard National Trust’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Vanguard National Trust's OGN Position: Q2 2026 in Review
Vanguard National Trust reduced its Organon & Co (OGN) stake by 74% in Q2 2026, selling an estimated $347 and leaving 10 shares worth $135. The position accounts for ﹤0.01% of the portfolio, ranked #781.
Vanguard National Trust first reported a position in OGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $234 in Q1 2026. 624 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Vanguard National Trust held 10 shares of Organon & Co worth $135 as of Q2 2026.
- Vanguard National Trust sold 29 Organon & Co shares in Q2 2026, an estimated $347.
- Organon & Co made up ﹤0.01% of Vanguard National Trust's portfolio in Q2 2026, its #781 holding.
- Vanguard National Trust first reported a position in Organon & Co in Q1 2026 and has held it in 2 quarters since.
- Vanguard National Trust's Organon & Co position peaked at $234 in Q1 2026.
- 624 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Vanguard National Trust's 13F filing for Q2 2026, filed 13 Aug 2026.